Beneficial effects of rosiglitazone and losartan combination in diabetic rats.

about

Beneficial effects of rosiglitazone and losartan combination in diabetic rats.

Item

http://www.wikidata.org/entity/Q50154239

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Beneficial effects of rosiglitazone and losartan combination in diabetic rats.

@en

Beneficial effects of rosiglitazone and losartan combination in diabetic rats.

@nl

type

Item

label

Beneficial effects of rosiglitazone and losartan combination in diabetic rats.

@en

Beneficial effects of rosiglitazone and losartan combination in diabetic rats.

@nl

prefLabel

Beneficial effects of rosiglitazone and losartan combination in diabetic rats.

@en

Beneficial effects of rosiglitazone and losartan combination in diabetic rats.

@nl

P1476

Beneficial effects of rosiglitazone and losartan combination in diabetic rats.

@en

P2093

Hayam Ateyya

http://www.w3.org/2001/XMLSchema#string

Manar A Nader

http://www.w3.org/2001/XMLSchema#string

P2860

PPARs: Protectors or Opponents of Myocardial Function?

Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options

The vascular endothelium and human diseases

PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1

Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review.

Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study).

Rosiglitazone via PPARγ-dependent suppression of oxidative stress attenuates endothelial dysfunction in rats fed homocysteine thiolactone.

The Association of Family History of Premature Cardiovascular Disease or Diabetes Mellitus on the Occurrence of Gestational Hypertensive Disease and Diabetes.

Electroacupuncture Reduces Weight Gain Induced by Rosiglitazone through PPARγ and Leptin Receptor in CNS

P304

1-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1139/CJPP-2017-0332

http://www.w3.org/2001/XMLSchema#string

P50

Nagla A El-Sherbeeny

P577

2017-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28892640

http://www.w3.org/2001/XMLSchema#string